Fibromyalgia – Competitive Landscape in 2021

This reports provides a data-driven overview of the current and future competitive landscape in fibromyalgia therapeutics.


GlobalData’s Fibromyalgia – Competitive Landscape in 2021 combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace.

Components of the report include:

Disease epidemiology

Marketed drugs assessment

Pipeline drugs assessment

Clinical trials assessment

Commercial assessment

Social media overview

Digital marketing overview

The accompanying Excel file includes the following datasets:

Marketed products exported from GlobalData's Pharmaceutical Intelligence Center

Pipeline-stage products exported from GlobalData's Pharmaceutical Intelligence Center

Upcoming catalysts in the fibromyalgia market exported from the Catalyst Calendar on GlobalData's Pharmaceutical Intelligence Center

A list of patent expiry dates for fibromyalgia products

Reasons to buy

Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.

Develop business strategies by understanding the trends shaping and driving the global fibromyalgia market.

Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global fibromyalgia market in the future.

Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.

Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.

Table of Contents

Table of Contents (PowerPoint Deck)

1 Preface

1.1 Table of Contents

1.2 Abbreviations

1.3 Related Reports

1.4 Upcoming Related Reports

2 Executive Summary

2.1 Key Findings

2.2 Key Events

3 Introduction

3.1 Report Scope

3.2 Disease Overview Epidemiology Overview

3.3 Epidemiology

4 Marketed Drugs Assessment

4.1 Marketed Drugs Overview

4.2 Marketed Drug Profiles

5 Pipeline Assessment

5.1 Pipeline Overview

5.2 Pipeline Breakdown by Region

5.3 Pipeline Breakdown by Molecule Type and Target

5.4 Drug Review Designations

5.5 Phase Transition Success Rates

5.6 Likelihood of Approval

6 Clinical Trial Assessment

6.1 Clinical Trials Overview by Phase

6.2 Overview by Region

6.4 Therapy Area Perspective

6.4 Leading Sponsors

6.5 Enrollment Analytics

6.6 Feasibility Analysis

7 Commercial Assessment

7.1 Upcoming Market Catalysts

8 Social Media and Digital Marketing

8.1 Key Twitter Chatter

8.2 Top Branded Websites

8.3 Trust Flow and Citation Flow

9 Appendix

9.1 Methodology

9.2 About the Authors

9.3 About GlobalData

9.4 Contact Us

9.5 Disclaimer


Discounts available for multiple purchases.
+44 20 7947 2745

Join our mailing list

Saved reports